COVIDSeq Assay (96 samples)

This low- to mid-throughput NGS assay enables labs to identify and track the emergence and prevalence of novel strains of SARS-CoV-2.Read More...
Select Product(s)

COVIDSeq Assay (96 samples) index 1

20049393

Price
 
 

COVIDSeq Assay (96 samples) index 2

20051772

Price
 
 
Accessory Products

COVIDSeq Positive Control

20051775

Price
 
 

Illumina COVIDSeq v4 Primer Pools, 384 Samples RUO

20065135

Price
 
 

Product Highlights

Key Features and Benefits
  • Accurate: Detects 98 targets on SARS-CoV-2 RNA for highly accurate detection of mutations
  • Comprehensive: Reports consensus sequence when +90 amplicons are detected
  • Quality Controlled: Built-in quality control in every reaction
  • Flexible: Seamless end-to-end workflow; temperature specification allows use of different thermocyclers

This amplicon-based next-generation sequencing (NGS) assay is designed to help clinical research labs identify novel strains of SARS-CoV-2. It includes 2019-nCoV primers to detect mutations and characterize RNA from the SARS-CoV-2 virus.

Rapid, Low-Throughput SARS-CoV-2 Detection

The Illumina COVIDSeq Assay accommodates a low number of samples. The workflow includes steps for viral RNA extraction, RNA-to-cDNA conversion, PCR, library preparation, sequencing, analysis, and report generation.

Design and Quality Control

The assay leverages a modified version of the publicly available ARTIC multiplex PCR protocol, with 98 amplicons designed to amplify SARS-CoV-2 virus-specific sequences, combined with proven Illumina sequencing technology. A 63°C annealing temperature at the PCR step improves variant analysis—providing important insight into the SARS-CoV-2 strain present in the sample.

An optional primer pool is also available. It is based on ARTIC community v4 design and includes 99 amplicons and no human controls. The kit volume is sufficient for 384 samples.

Upload consensus sequence information (FASTA file) into open software tools to assign lineage and annotate mutations. For added convenience, upload files to the NCBI and/or GISAID App directly through BaseSpace Sequencing Hub.

Questions about whether this assay is a good fit for your needs? Contact Us today.

Frequently Purchased Together

High-Level Workflow

 

Related Products

COVIDSeq Test (RUO Version)

This high-throughput next-generation sequencing (NGS) assay detects mutations from the SARS-CoV-2 virus.


Respiratory Pathogen ID/AMR Enrichment Panel Kit (Powered by IDbyDNA Explify)

This NGS panel targets >280 respiratory pathogens (including SARS-CoV-2) and 1200+ antimicrobial resistance alleles, with data analysis powered by IDbyDNA.


Respiratory Virus Oligo Panel

Highly sensitive detection and characterization of common respiratory viruses, including COVID-19 strains, with comprehensive, rapid target enrichment sequencing.